Foundation Fighting Blindness Retinal Degeneration Fund → Opus Genetics, Inc. IRD

Stake: 4.66% Shares: 3,792,171 CUSIP: 67577R102 Class: Common Stock, $0.0001 par value per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

1 transaction

0 buys · 1 sales · 0 awards/exercises

Issuer Cluster

1 13D/G filings on this issuer

0 other filings besides this one

Filer Track Record

1 filings by this filer

0 other filings in the data moat

Short Interest · settle 2026-09-30

DTC 6.05

13,013,222 shares short · +3.5% vs prior

Post-Filing Returns · since 2026-05-18 on IRD

+1 day

0.0%

+5 days

0.0%

+30 days

0.0%

+60 days

-19.3%

+90 days

—

+180 days

—

Anchor price 4.05 on closest trading day on/after 2026-05-18. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-09-30	Foundation Fighting Blindness Retinal Degeneration Fund	director	Sale	556,000	$4.96	$2.76M

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →